Daxing Biomedical Base: Create "China Medicine Valley" with international influence

As pharmaceutical health and information technology have become the "dual engines" that promote the development of industrial innovation in Beijing, Daxing Biomedical Base focuses on the innovative application of smart medical and industrial Internet. Essence

The Daxing Biopharmaceutical Base in Zhongguancun Science and Technology Park is located in the south of Daxing District, Beijing. At present, there are more than 4,000 enterprises in the area. In 2021, the industrial scale exceeded 160 billion yuan. Biological Industry Bases "" National New Industrialization Industry Demonstration Base "," The First Batch of Strategic Emerging Industry Clusters "," Leading Brand of the China Health Industry Alliance "and" Best Park for Biomedicine ".

As a pilot of the national advanced manufacturing industry and modern service industry, Daxing Biomedical Base focuses on the three central tasks of “fully promoting the work of the zone, accelerating infrastructure carrying capacity, and comprehensively strengthened service awareness”. The new path of integration and development has transformed from traditional biological manufacturing to layout in cutting -edge fields, increases the proportion of modern service industries in the economic structure, and realizes the dual envelopes of the pharmaceutical manufacturing industry and modern service industry.

200 high -tech enterprises realize "AI+Medical" dual envelopes

With the development opportunities of the integrated pilot of the base, more and more functional extensions have been achieved between the manufacturing enterprises of the base and the modern service industry. According to the announcement of the final round of national high -tech enterprises announced by the Ministry of Science and Technology on March 8th, the total number of national high -tech enterprises in the park reached 200, mainly biomedical enterprises, and some electronic information and high -tech services. Enterprise was selected. In recent years, the base has actively promoted the development of medical networking, drug networking, health information services, remote medical services, and health big data. It encourages the upgrading of the enterprises in the direction of digitalization, intelligence, and convenience, and in advanced technologies in electronic information and cloud computing and other fields Close to actively promote the realization of the new generation of information technology and medicine health.

At present, "AI+Medical" has become an effective assistance and strong support for the pharmaceutical health industry. Daxing Biopharmaceutical Base actively cooperates with the park enterprises to carry out 5G application -based production and research and development activities, and encourage enterprises to carry out the application scenarios of new technologies and new products and new products in the region. Projects such as 3D pathological databases and Hengdao pathology and medicine laboratories have been implemented, which has improved the level of bases in smart medical care and AI pharmaceuticals, realized the dual envelopes of the digital economy and the pharmaceutical and health industry, and promoted the layout of the entire industry chain of life and health.

The new crown vaccine produced by Kexing Zhongwei has been approved in more than 40 countries and regions, with an annual production capacity of more than 2 billion doses. In order to do a good job of quality control testing, Kexing Zhongwei has established an information management system. The new crowns used vaccines used in China are all independent packaging. The packaging box has an exclusive traceability code, which can achieve the vaccine from production and production, and the vaccine can be produced and produced. Full trace of circulation to vaccination.

Hot -view biology has constructed the above R & D technology platform with the above R & D technology platform with the core of transformation technology, magnetic particle chemical light emitting technology, sugar capture technology, genetic restructuring and monoclonal antibody technology. Application in the field of full diagnostic scenarios.

The neurosurgery plan software developed by Huake accurately and independent has reached the international leading level in key technologies such as multi -mode image data processing, segmentation fusion, registration and allocation, and brain -brain -proof correction.

Chengyi Tong used digitalization methods to help biopharmaceutical companies realize digital transformation. It has now become the leading overall solution supplier of the intelligent manufacturing system in the pharmaceutical industry, rehabilitation equipment, rehabilitation assistive device research and development, and rehabilitation pension professional technical service providers. Essence

Focus on cutting -edge technology and create a highland for the transformation of results

Daxing Biomedical Base not only gathered a large number of leading enterprises in the pharmaceutical industry, but also became an important carrying area for my country's pharmaceutical scientific and technological innovation with the resource advantages of the hospital. One type of new medicines and 9 national innovation medical devices.

The base has formed resource gathering in the research institutes, various service platforms, and innovative talents. The innovation and development of the pharmaceutical industry provides strong intellectual support. The base has 4 academicians and expert workstations, 17 post -doctoral research workstations, 28 corporate science and technology associations, and introduced more than 600 high -end innovative talents.

The pharmaceutical base has now been fully launched and expanded. Based on the current 13.4 square kilometers, it expands 9.1 square kilometers to form a 22.5 square kilometer biomedical development area. In the future, the base will deepen cooperation with scientific research institutes and universities, promote the transformation of results, and try to establish a transformation channel with scientific research institutes and hospitals, accelerate the construction of clinical research hospitals and innovation centers of Capital Medical University Two -way docking with the clinical research of enterprises in the park and the application of hospital applications.

According to the relevant person in charge of the base, Daxing Biomedical Base will continue to play the advantages of existing industries, undertake the transformation of pharmaceutical health science and technology achievements in the "three cities and one district", bigger and stronger vaccine plates and high -end medical equipment sections, focusing on building a gene cell treatment sector 2. Layout the digital health sector, and strengthen the subdivision track of the development of each section, focus on the transformation of scientific and technological achievements, allocate resource elements, and build an industrial ecology. Optimize the business environment and build a "housekeeper" service mechanism

What attracted so many industry -headed companies and scientific research forces to settle in Daxing Biomedical Base?

On the one hand, the biomedical base has a comprehensive policy service system, a number of policies such as national key R & D plans, national key laboratories, and Beijing Science and Technology Plan Projects have favored the formation of the high -end biomedical industry gathering area. For example, according to the "Several measures for the development of the pharmaceutical health industry (trial)" issued in November last year, in terms of supporting major results and innovative resources, it is After the leadership of the domain leadership, the project with international competition potential, and the strategic project with the overall role of leading the overall role can be supported by 30%of the actual investment in fixed assets (except real estate and land). The project is up to 300 million yuan. In terms of medicines, for a class of chemicals, a class of biological products, and one type of Chinese medicine, according to the different stages of the completion of the clinical trials of phase I, II, and phase III, 10 million yuan, 200 million yuan, and 40 million yuan are given to complete the support of the completion of the clinical trials of stage I, III A single enterprise supports up to 100 million yuan each year.

On the other hand, Daxing Biopharmaceutical Base takes "precise and efficient, integrated sharing" as the principles of work guidance, continuously optimizes and improves the service mechanism, and strives to achieve "steward -type" accurate services for enterprises. Biopharmaceutical bases visit enterprises and hold seminars to deeply understand the dilemma and needs facing enterprise development, such as production venues, financing, talent recruitment, construction of medical testing laboratories, etc., establish a demand ledger, set the duration of the settlement, according to the enterprise according to the enterprise Characteristic needs, "one enterprise, one policy", and continue to follow up and pay attention to the development of the enterprise. By increasing the feedback rate and resolution rate, the solution cycle is shortened. At the same time, through this kind of visit, research, and accurate services, the base can better summarize the common problems, so as to continuously explore efficient solution mechanisms, and can be reflected in policy reform.

It is reported that the development of integration and mutual assistance will be an important step for this year's biomedical base to improve corporate service efficiency. Specifically, there are five aspects: first, the medical CXO conference, the national IVD forum, etc. are held to set up an industry exchange platform to provide enterprises with opportunities for docking supply and demand; The innovation center cooperates to further give full play to the advantages of base scientific research resources; the third is to rely on the Entrepreneur Federation to establish a segmented industry alliance; the fourth is to plan the transformation center of the construction of innovation achievements with the Central Inspection Institute and the School of Medicine, and promote the truly transformation of scientific research results to benefit people's livelihood to benefit people's livelihood Medical resources to reduce the idle rate of scientific and technological achievements; Fifth, relying on Tsinghua Biological Safety Expert Think Tank to plan the special planning of biological safety in the park in advance.

The relevant person in charge of the base said that at present, the park is still mainly manufacturing from the industrial distribution. The service industry is relatively weak, the proportion is relatively small, and the service industry has a limited role in the high -quality development of the manufacturing industry. The new requirement of the "Five Sons" linkage, adhere to the new path of "technology+medicine+finance" industry integration and development, accelerate the development of scientific and technological services and financial services in the park, promote the integration and development of manufacturing and service industry, and focus on the development of the park from the speed and scale of attention to attention. The change of quality and efficiency, building a "Chinese medicine Valley" with international influence. ("China Strategic Emerging Industry" magazine reporter Li Ziji)

- END -